相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Updates in the Incidence, Pathogenesis, and Management of Cancer and Venous Thromboembolism
Laura Girardi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2023)
Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014-2019)
Mark Joy et al.
HEART (2023)
Bleeding with concomitant ibrutinib and oral anticoagulant therapy: A population-based cohort study
Neil Dhopeshwarkar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2023)
Trends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010-2020
Geetha S. Iyer et al.
JAMA NETWORK OPEN (2023)
Risk of major bleeding associated with concomitant use of anticancer drugs and direct oral anticoagulant in patients with cancer and atrial fibrillation
Chun-Li Wang et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016
Shirin Ardeshirrouhanifard et al.
PHARMACOTHERAPY (2022)
Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice
Nicola Ferri et al.
PHARMACEUTICS (2022)
Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case-control study in the National COVID Cohort Collaborative (N3C)
Olga Kravchenko et al.
BMJ OPEN (2022)
Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer
Leila S. Otten et al.
EUROPEAN RESPIRATORY REVIEW (2022)
Complexity and clinical significance of drug-drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT) (Aug, 10.1007/s00520-022-07235-8, 2022)
Nikolaos Tsoukalas
SUPPORTIVE CARE IN CANCER (2022)
Cancer treatment and atrial fibrillation: use of pharmacovigilance databases to detect cardiotoxicity
Kalliopi Keramida et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system
Tomiko Sunaga et al.
CONTRACEPTION (2021)
Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
Angela Duvalyan et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries
Kevin M. Wheelock et al.
JAMA NETWORK OPEN (2021)
Cancer and atrial fibrillation: Epidemiology, mechanisms, and anticoagulation treatment
Danilo Menichelli et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2021)
Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation
Sylvie Perreault et al.
PHARMACOTHERAPY (2020)
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism
Olivia S. Costa et al.
BLOOD ADVANCES (2020)
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
Thomas L. Ortel et al.
BLOOD ADVANCES (2020)
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia
Milo Gatti et al.
CURRENT HEART FAILURE REPORTS (2020)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
Craig T. January et al.
CIRCULATION (2019)
A Comparison Study of Algorithms to Detect Drug-Adverse Event Associations: Frequentist, Bayesian, and Machine-Learning Approaches
Minh Pham et al.
DRUG SAFETY (2019)
Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH
Aurelien Delluc et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Review of Statistical Methodologies for Detecting Drug-Drug Interactions Using Spontaneous Reporting Systems
Yoshihiro Noguchi et al.
FRONTIERS IN PHARMACOLOGY (2019)
Cabozantinib and apixaban: an hitherto unreported interaction
Daniele Santini et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2019)
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication
Meritxell Bellet et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Anticancer Drug-Related Nonvalvular Atrial Fibrillation: Challenges in Management and Antithrombotic Strategies
Antonella Tufano et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)
Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions
Hanno Riess et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer
Wesley T. O'Neal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Anticoagulants Could Be a Victim of Enzalutamide
Krishna Gundabolu
JOURNAL OF ONCOLOGY PRACTICE (2017)
Management of Anticoagulation in Patients With Prostate Cancer Receiving Enzalutamide
Joseph J. Shatzel et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Anticoagulation and Enzalutamide: Caution Over Convenience
Hanny Al-Samkari et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Direct Oral Anticoagulants: A Quick Guide
Julia Sikorska et al.
EUROPEAN CARDIOLOGY REVIEW (2017)
A Comprehensive Overview of Direct Oral Anticoagulants for the Management of Venous Thromboembolism
Anthony J. Comerota et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2016)
Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data
Heba Ibrahim et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2016)
Epidemiology of cancer-associated venous thrombosis
Jasmijn F. Timp et al.
BLOOD (2013)
Incidence of venous thromboembolism in patients with cancer - A cohort study using linked United Kingdom databases
Alex J. Walker et al.
EUROPEAN JOURNAL OF CANCER (2013)
Data Mining of the Public Version of the FDA Adverse Event Reporting System
Toshiyuki Sakaeda et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006
D. P. Cronin-Fenton et al.
BRITISH JOURNAL OF CANCER (2010)
Identifying patterns of adverse event reporting for four members of the angiotensin II receptor blockers class of drugs: revisiting the Weber effect
Mara A. McAdams et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
P Prandoni et al.
BLOOD (2002)
In vitro tests for predicting drug-drug interactions:: The need for validated procedures
P Kremers
PHARMACOLOGY & TOXICOLOGY (2002)
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
EP van Puijenbroek et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the USFDA's spontaneous reports database
A Szarfman et al.
DRUG SAFETY (2002)
分享论文
